» Articles » PMID: 26280832

Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia Coli Isolates from Human and Pig in Taiwan

Overview
Journal PLoS One
Date 2015 Aug 18
PMID 26280832
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the efficacy of fosfomycin against extended-spectrum β-lactamases (ESBL) producing Escherichia coli in Taiwan and the resistance mechanisms and characterization of human and pig isolates, we analyzed 145 ESBL-producing isolates collected from two hospitals (n = 123) and five farms (n = 22) in Taiwan from February to May, 2013. Antimicrobial susceptibilities were determined. Clonal relatedness was determined by PFGE and multi-locus sequence typing. ESBLs, ampC, and fosfomycin resistant genes were detected by PCR, and their flanking regions were determined by PCR mapping and sequencing. The fosfomycin resistant mechanisms, including modification of the antibiotic target (MurA), functionless transporters (GlpT and UhpT) and their regulating genes such as uhpA, cyaA, and ptsI, and antibiotic inactivation by enzymes (FosA and FosC), were examined. The size and replicon type of plasmids carrying fosfomycin resistant genes were analyzed. Our results revealed the susceptibility rates of fosfomycin were 94% for human ESBL-producing E. coli isolates and 77% for pig isolates. The PFGE analysis revealed 79 pulsotypes. No pulsotype was found existing in both human and pig isolates. Three pulsotypes were distributed among isolates from two hospitals. ISEcp1 carrying blaCTX-M-group 9 was the predominant transposable elements of the ESBL genes. Among the thirteen fosfomycin resistant isolates, functionless transporters were identified in 9 isolates. Three isolates contained novel amino acid substitutions (Asn67Ile, Phe151Ser and Trp164Ser, Val146Ala and His159Tyr, respectively) in MurA (the target of fosfomycin). Four isolates had fosfomycin modified enzyme (fosA3) in their plasmids. The fosA3 gene was harboured in an IncN-type plasmid (101 kbp) in the three pig isolates and an IncB/O-type plasmid (113 kbp) in the human isolate. In conclusion, we identified that 6% and 23% of the ESBL-producing E. coli from human and pigs were resistant to fosfomycin, respectively, in Taiwan. No clonal spread was found between human and pig isolates. Functionless transporters were the major cause of fosfomycin resistance, and the fosA3-transferring plasmid between isolates warrants further monitoring.

Citing Articles

Fosfomycin resistance mechanisms in : an increasing threat.

Mattioni Marchetti V, Hrabak J, Bitar I Front Cell Infect Microbiol. 2023; 13:1178547.

PMID: 37469601 PMC: 10352792. DOI: 10.3389/fcimb.2023.1178547.


Emergence of Fosfomycin Resistance by Plasmid-Mediated Genes in Uropathogenic ESBL-Producing Isolates in Mexico.

Galindo-Mendez M, Navarrete-Salazar H, Baltazar-Jimenez F, Munoz-de la Paz E, Sanchez-Mawcinitt M, Gomez-Pardo A Antibiotics (Basel). 2022; 11(10).

PMID: 36290041 PMC: 9598328. DOI: 10.3390/antibiotics11101383.


Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant .

Wang Y, Chen Y, Hung I, Chu P, Chang Y, Lin Y Front Microbiol. 2022; 13:816806.

PMID: 35173700 PMC: 8841775. DOI: 10.3389/fmicb.2022.816806.


Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in .

Cattoir V, Pourbaix A, Magnan M, Chau F, de Lastours V, Felden B Front Microbiol. 2020; 11:575031.

PMID: 33193186 PMC: 7607045. DOI: 10.3389/fmicb.2020.575031.


Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Isolated in Clinical Urine Samples.

Sorlozano-Puerto A, Lopez-Machado I, Albertuz-Crespo M, Martinez-Gonzalez L, Gutierrez-Fernandez J Antibiotics (Basel). 2020; 9(9).

PMID: 32847131 PMC: 7558542. DOI: 10.3390/antibiotics9090534.


References
1.
Gutierrez L, Ocampo L, Rosario C, Sumano H . Pharmacokinetics of disodium fosfomycin in broilers and dose strategies to comply with its pharmacodynamics versus Escherichia coli. Poult Sci. 2010; 89(10):2106-15. DOI: 10.3382/ps.2010-00892. View

2.
Coque T, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L . Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis. 2008; 14(2):195-200. PMC: 2600198. DOI: 10.3201/eid1402.070350. View

3.
Diestra K, Juan C, Curiao T, Moya B, Miro E, Oteo J . Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother. 2008; 63(1):60-6. DOI: 10.1093/jac/dkn453. View

4.
Carattoli A, Bertini A, Villa L, Falbo V, Hopkins K, Threlfall E . Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005; 63(3):219-28. DOI: 10.1016/j.mimet.2005.03.018. View

5.
Carattoli A . Plasmids and the spread of resistance. Int J Med Microbiol. 2013; 303(6-7):298-304. DOI: 10.1016/j.ijmm.2013.02.001. View